441
The European Union Committee of Experts of Rare Diseases (EUCERD) adopted a recommendation in the area of facilitating the exchange of scientific information on orphan medicinal products. It involves the creation of an Information Flow between individual Member States and the EU that would bridge existing knowledge gaps, especially at the time of marketing authorisation. The recommendation should ultimately accelerate access to approved orphan medicinal products, while encouraging pricing and reimbursement decisions based on the value of the orphan medicinal products and promoting good medical practices throughout the EU. To read the full document, please, visit EUCERD’s website.